Industry Information | Huateng Pharma | Pharmaceutical chemical reagents, PEG derivatives

Hello! Welcome to Huateng Pharma

Hotline：+86 0731-89916275 sales@huatengusa.com

中文 / English

Batch Search Chem structure Search

High-end suppliers of chemical, biological reagents, pharmaceutical intermediates and APIs

Quick Links >> Chemical Products Biological Reagent PEG Derivatives Pharma Intermediates COVID-19 Vaccine Excipients

Current Location：Home > Industry Information

Industry Information

What Are The World's Top Selling Drugs?
by Journalist Huateng
Let's find the top 10 best-selling drugs in the world of 2020.
Top 10 Oncology Pharmaceutical Companies 2020
by Journalist Huateng
The top ten pharmaceutical companies based on global oncology revenue in 2020.
Nature: A 100-year History of The Human Fight Against Diabetes
by Journalist Huateng
2021 is the 100th anniversary of the discovery of insulin. Before insulin was discovered, diabetes was considered a fatal disease, and many people could fall into coma and then die within a short time after diagnosis. In order to get rid of diabetes, people have tried various ways.
The Differences And Connections Between Tumors And Cancers
by Journalist Huateng
Cancer is a terrible disease with high morbidity and mortality. In daily life, many people compare tumors with cancers, and think that if they grow tumors, they are suffering from cancer. Others believe that malignant tumors are cancers. What are the facts? What are the differences and connections between tumor and cancer?
Nature: Vaccine Development Timeline - 20 Major Milestones
by Journalist Huateng
Here we share vaccine development milestones from Nature to navigate the breakthroughs in vaccine development.
New Drug Approvals & Upcoming FDA Approvals 2021
by Journalist Huateng
In the first half of 2021, the U.S. FDA approved a total of 29 innovative drugs.
Moderna Launched The Clinical Trial of Its First Quadrivalent Seasonal Influenza mRNA Vaccine And Completed The First Batch of Vaccinations
by Journalist Huateng
On July 7, Moderna announced the first participants have been dosed in the Phase 1/2 study of mRNA-1010. Its research vaccine mRNA-1010 is a quadrivalent seasonal influenza vaccine candidate targeting WHO recommendations including A H1N1, H3N2 and influenza B Yamagata and Victoria lineages. The press release states that it is Moderna's first seasonal flu vaccine candidate product that has entered clinical development.
Enzalutamide Has The Potential For Treating COVID-19
by Journalist Huateng
Enzalutamide, typically used to treat prostate cancer could be explored for treating patients with COVID-19. Researchers found that, as a type of testosterone-blocker, enzalutamide also reduced the ability of the SARS-CoV-2 coronavirus to infect lung cells in the lab.
COVID-19 Vaccine Success Accelarates R&D of mRNA-based Cancer Vaccines
by Journalist Huateng
The success of mRNA technology in the development of COVID-19 vaccines has also stimulated researchers' interest in mRNA-based therapies.
Top 8 Blockbuster Peptide Drugs
by Journalist Huateng
The top 8 blockbuster peptide drugs have a combined sales of more than US$18 billion, including Trulicity, Victoza, Ozempic, Octreotide, Copaxone, Teriparatide, Goserelin, Lupron.
Antiviral Nucleoside and Nucleotide Analogs
by Journalist Huateng
Nucleoside and nucleotide analogs are used as antiviral agents for several infections such as different types of viral hepatitis, human immunodeficiency virus infection and acquired immune deficiency syndrome (HIV/AIDS) and herpes virus infections.
Latest Treatment of Hepatitis B - Pegylated Interferon-α & Nucleoside Analogs
by Journalist Huateng
Currently, there are two treatments for hepatitis B virus infection, pegylated interferon-α (IFN-α) and nucleos(t)ide analogues (NAs).

Links

FAQs

Copyright © 2013-2020 Hunan HuaTeng Pharmaceutical Co., Ltd. All right reserved Tel: +86 0731 89916275, +1 857-928-2050 E-mail: sales@huatengusa.com

Address: Lugu Business Plaza E1, Yuelu District, Changsha City, Hunan Province, P.R. China. ZIP Code: 410006

Tel

+86 0731 89916275
Email
sales@huatengusa.com
To Top